diazoxide has been researched along with ATLL in 1 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holmuhamedov, E | 1 |
| Lewis, L | 1 |
| Bienengraeber, M | 1 |
| Holmuhamedova, M | 1 |
| Jahangir, A | 1 |
| Terzic, A | 1 |
1 other study available for diazoxide and ATLL
| Article | Year |
|---|---|
Suppression of human tumor cell proliferation through mitochondrial targeting.
Topics: Antineoplastic Agents; Calcium Channel Blockers; Calcium Signaling; Cell Division; Diazoxide; DNA, M | 2002 |